Avenue Therapeutics Inc’s recently made public that its 10% Owner Davidow Robert L unloaded Company’s shares for reported $49600.0 on Dec 11 ’23. In the deal valued at $0.14 per share,353,000 shares were sold. As a result of this transaction, Davidow Robert L now holds 22,000 shares worth roughly $3300.0.
Then, Davidow Robert L sold 264,000 shares, generating $36,960 in total proceeds. Upon selling the shares at $0.14, the 10% Owner now owns 681,000 shares.
Before that, Fortress Biotech, Inc. bought 418,410 shares. Avenue Therapeutics Inc shares valued at $301,255 were divested by the 10% Owner at a price of $0.72 per share. As a result of the transaction, Fortress Biotech, Inc. now holds 1,032,390 shares, worth roughly $0.15 million.
Price Performance Review of ATXI
On Friday, Avenue Therapeutics Inc [NASDAQ:ATXI] saw its stock jump 1.22% to $0.15. Over the last five days, the stock has gained 0.88%. Avenue Therapeutics Inc shares have fallen nearly -7.58% since the year began. Nevertheless, the stocks have fallen -88.10% over the past one year. While a 52-week high of $1.36 was reached on 01/04/24, a 52-week low of $0.11 was recorded on 02/07/24. SMA at 50 days reached $0.1519, while 200 days put it at $0.4926. A total of 0.62 million shares were traded, compared to the trading of 0.74 million shares in the previous session.
Levels Of Support And Resistance For ATXI Stock
The 24-hour chart illustrates a support level at 0.1437, which if violated will result in even more drops to 0.1387. On the upside, there is a resistance level at 0.1519. A further resistance level may holdings at 0.1551. The Relative Strength Index (RSI) on the 14-day chart is 45.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0045, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.67%. Stochastics %K at 25.02% indicates the stock is a holding.
How much short interest is there in Avenue Therapeutics Inc?
A steep rise in short interest was recorded in Avenue Therapeutics Inc stocks on Mar 15, 2024, dropping by 24350.0 shares to a total of 0.31 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 0.34 million shares. There was a decline of -7.77%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.71% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.15.
